The GreenVax project aims to produce vaccines from the tobacco plant on a large-scale.
Financing
In February 2010, the GreenVax project received $40m funding from the Defense Advanced Research Projects Agency (DARPA) of the US Department of Defense. The public-private-partnership is largely financed by DARPA. The G-Con and A&M will fund $21m towards the project. The development of the tobacco-based vaccine production technology was funded through the Texas Emerging Technology Fund. In August 2010, the project also received $4m funds from the Texas Military Preparedness Commission (TMPC).
"Licensing
The new GreenVax plant will be licensed by iBio Inc. The company will provide the iBioLaunch technology platform and provide technology transfer services to G-Con to be implemented in the Bryan facility. ( IBIO : Amex ) "
To follow my postings on ihub use this link : Ihub person mark Feedback is allways appreciated, as are other (annotated) picks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.